Instil Bio Stock Performance
| TIL Stock | USD 7.42 0.33 4.65% |
The company retains a Market Volatility (i.e., Beta) of 2.15, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Instil Bio will likely underperform. At this point, Instil Bio has a negative expected return of -0.81%. Please make sure to check out Instil Bio's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Instil Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Instil Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return (1.66) | Five Day Return 0.14 | Year To Date Return (37.09) | Ten Year Return (98.66) | All Time Return (98.66) |
Last Split Factor 1:20 | Last Split Date 2023-12-08 |
1 | Is Instil Bio Inc. stock attractive for long term wealth building - July 2025 Action Verified Swing Trading Watchlist - newser.com | 11/06/2025 |
2 | Instil Bio Narrows Losses And Impresses Wall Street Analysts - Finimize | 11/12/2025 |
3 | Is Instil Bio Inc. stock attractive for long term wealth building - Weekly Trade Recap High Return Trade Opportunity Guides - newser.com | 11/14/2025 |
4 | Citizens reiterates Market Perform rating on Instil Bio stock - Investing.com | 11/18/2025 |
5 | Why analysts remain bullish on Instil Bio Inc. stock - Market Entry Points Low Cost Stock Picks - Bollywood Helpline | 12/24/2025 |
6 | Instil Bios Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco | 01/06/2026 |
7 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL | 01/13/2026 |
| Begin Period Cash Flow | 10.7 M | |
| Total Cashflows From Investing Activities | 54 M |
Instil Bio Relative Risk vs. Return Landscape
If you would invest 1,502 in Instil Bio on November 6, 2025 and sell it today you would lose (760.00) from holding Instil Bio or give up 50.6% of portfolio value over 90 days. Instil Bio is generating negative expected returns assuming volatility of 7.2659% on return distribution over 90 days investment horizon. In other words, 65% of stocks are less volatile than Instil, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Instil Bio Target Price Odds to finish over Current Price
The tendency of Instil Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 7.42 | 90 days | 7.42 | about 87.53 |
Based on a normal probability distribution, the odds of Instil Bio to move above the current price in 90 days from now is about 87.53 (This Instil Bio probability density function shows the probability of Instil Stock to fall within a particular range of prices over 90 days) .
Instil Bio Price Density |
| Price |
Predictive Modules for Instil Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Instil Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Instil Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Instil Bio is not an exception. The market had few large corrections towards the Instil Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Instil Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Instil Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.19 | |
β | Beta against Dow Jones | 2.15 | |
σ | Overall volatility | 3.10 | |
Ir | Information ratio | -0.16 |
Instil Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Instil Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Instil Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Instil Bio generated a negative expected return over the last 90 days | |
| Instil Bio has high historical volatility and very poor performance | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (74.14 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (55.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL |
Instil Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Instil Stock often depends not only on the future outlook of the current and potential Instil Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Instil Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.5 M | |
| Cash And Short Term Investments | 113.3 M |
Instil Bio Fundamentals Growth
Instil Stock prices reflect investors' perceptions of the future prospects and financial health of Instil Bio, and Instil Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Instil Stock performance.
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | 54.08 M | ||||
| Shares Outstanding | 6.78 M | ||||
| Price To Earning | 18.31 X | ||||
| Price To Book | 0.40 X | ||||
| Price To Sales | 55,330 X | ||||
| Gross Profit | 138 K | ||||
| EBITDA | (62.53 M) | ||||
| Net Income | (74.14 M) | ||||
| Cash And Equivalents | 354.61 M | ||||
| Cash Per Share | 2.73 X | ||||
| Total Debt | 86.89 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 8.51 X | ||||
| Book Value Per Share | 17.76 X | ||||
| Cash Flow From Operations | (55.7 M) | ||||
| Earnings Per Share | (11.35) X | ||||
| Market Capitalization | 48.9 M | ||||
| Total Asset | 263.57 M | ||||
| Retained Earnings | (655.12 M) | ||||
| Working Capital | 116.57 M | ||||
About Instil Bio Performance
By examining Instil Bio's fundamental ratios, stakeholders can obtain critical insights into Instil Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Instil Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.26) | (0.27) | |
| Return On Assets | (0.25) | (0.27) | |
| Return On Equity | (0.50) | (0.53) |
Things to note about Instil Bio performance evaluation
Checking the ongoing alerts about Instil Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Instil Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Instil Bio generated a negative expected return over the last 90 days | |
| Instil Bio has high historical volatility and very poor performance | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (74.14 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (55.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL |
- Analyzing Instil Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Instil Bio's stock is overvalued or undervalued compared to its peers.
- Examining Instil Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Instil Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Instil Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Instil Bio's stock. These opinions can provide insight into Instil Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Instil Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Instil Bio's market price often diverges from its book value, the accounting figure shown on Instil's balance sheet. Smart investors calculate Instil Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Instil Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.